ELRiSE MDS

A Phase 3, Multicenter, Open-Label, Randomized Trial to Compare the Efficacy and Safety of Elritercept Versus Epoetin Alfa for the Treatment of Anemia Due to IPSS-R Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes in ESA-naïve Adult Participants Who Require Red Blood Cell Transfusions

Near Add Your Location

Sorting 28 by

Louisiana State University Health Science Center
LSU Health New Orleans
New Orleans, LA
  • Not yet accepting

Center of Excellence

Vanderbilt-Ingram Cancer Center
Henry-Joyce Cancer Clinic
Nashville, TN
  • Not yet accepting
WVU Cancer Institute
Mary Babb Randolph Cancer Center
Morgantown, WV
  • Not yet accepting
American Oncology Partners of Maryland (Bethesda)
The Center for Cancer & Blood Disorders - Bethesda
Bethesda, MD
  • Not yet accepting
Tranquil Clinical Research
Webster, TX
  • Not yet accepting
MidAmerica Cancer Center
American Oncology Partners
Kansas City, MO
  • Not yet accepting

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print a patient-friendly report to share with your patient.

(888) 803-1766

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.